Iris atrophy after administration of Dexycu: Additional evidence and possible mechanism for a rare complication
Purpose: To report the observation of iris atrophy with the use of Dexycu in cataract surgery and describe a possible mechanism for this complication. Observations: Between 2020 and 2021, 2 patients underwent cataract surgery procedures with the use of Dexycu and experienced iris atrophy. The first...
Main Authors: | Azraa Ayesha, Ryan T. Wallace, Anthony P. Mai, Rachel G. Simpson, Craig J. Chaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | American Journal of Ophthalmology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993623000142 |
Similar Items
-
Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy
by: Shah TJ, et al.
Published: (2018-11-01) -
An unusual case of a pigment epithelial cyst masquerading as a uveal melanoma after zoster ophthalmicus-related iris atrophy
by: Jordan Finley, et al.
Published: (2023-06-01) -
Quantification of Iris Atrophy by Swept-Source Optical Coherence Tomography in Posner–Schlossman Syndrome
by: Xiaoqin Yan, et al.
Published: (2022-11-01) -
Anterior Uveitis with Posterior Synechia and Iris Atrophy Following Implantation of a Phakic Intraocular Lens
by: Mohammadpour M, et al.
Published: (2020-05-01) -
A case of morgagnian cataract mimicking an iris tumor
by: Paolo Mora, et al.
Published: (2020-06-01)